ZVRA financials
Zevra Therapeutics (ZVRA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ZVRA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $106.47M | $89.99M | -$4.23M | $83.23M | 1.35 |
| 2024 | $23.61M | $16.20M | -$87.00M | -$105.51M | -2.28 |
| 2023 | $27.46M | $24.52M | -$49.60M | -$46.05M | -1.30 |
| 2022 | $10.16M | $9.94M | -$42.56M | -$26.77M | -0.78 |
| 2021 | $28.65M | $26.59M | $7.73M | -$8.55M | -2.11 |
| 2020 | $13.29M | $11.98M | -$5.61M | -$12.76M | -3.21 |
- ZVRA revenue was $106.47M in fiscal 2025, net income $83.23M.
Updated 2026-11-07 11:56 UTC